Recent studies found that depletion of RNF43 enhanced tumor growth in GI cancers and conferred resistance to DNA-damage-inducing chemotherapies and γ-radiation in gastric cancer cells (Neumeyer et al., 2019, 2020). Here, RNF43 is linked to neoplasm.